Fiasp ® (insulin aspart) injection 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Fiasp ® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to Fiasp ® or one of its excipients.

Fiasp ® (insulin aspart) injection 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Fiasp ® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to Fiasp ® or one of its excipients.

Fiasp solution for injection in vial can be used for CSII in pumps suitable for insulin infusion and will cover both the bolus insulin requirement (approximately 50%) and basal insulin. It can be administered in accordance with the instructions provided by …

• FIASP is a rapid-acting human insulin analog indicated to improve glycemic control in adults with diabetes mellitus (1). Individualize and adjust the dosage of FIASP based on route of...

Fiasp (insulin aspart) is a fast-acting insulin used to lower blood sugar (glucose) levels in patients with type 1 and type 2 diabetes, who require insulin for treatment. Fiasp reaches the bloodstream 2.5 minutes after injection and reaches its peak level in about 1 hour.

2023年6月21日 · Injection: 100 units of insulin aspart per mL (U-100) is available as a clear and colorless solution in: • 10 mL multiple-dose vial - • 3 mL single-patient-use FIASP FlexTouch pen - • 3 mL ... FIASP is contraindicated: • During episodes of hypoglycemia [see Warnings and Precautions (5.3)].

Fiasp® (insulin aspart injection) is indicated for treatment of adult and pediatric patients (>2 years old) with diabetes mellitus who require mealtime insulin for the control of hyperglycemia (see CLINICAL TRIALS). Fiasp® should generally be used in a regimen with intermediate- or long-acting insulin (plus

Fiasp ® (insulin aspart) injection 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Fiasp ® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to Fiasp ® or one of its excipients.

The insulin aspart, or “Fiasp®”, in Fiasp® 10 mL vial is a fast-acting insulin used to treat diabetes mellitus in adults, adolescents and children aged 1 year and above.

2025年2月11日 · Fiasp 100IU/ml Solution for Injection is used for blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin that helps to lower blood sugar levels after meals and reduce the chances of developing serious complications of diabetes.